Signify Health Inc. [NYSE: SGFY] closed the trading session at $12.34 on 06/01/22. The day’s price range saw the stock hit a low of $11.96, while the highest price level was $13.67. The company report on May 4, 2022 that Signify Health Announces First Quarter 2022 Results Maintains 2022 Full Year Guidance.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
The stocks have a year to date performance of -13.22 percent and weekly performance of -3.52 percent. The stock has been moved at -9.20 percent over the last six months. The stock has performed -13.40 percent around the most recent 30 days and changed -9.80 percent over the most recent 3-months.
If compared to the average trading volume of 1.52M shares, SGFY reached to a volume of 4098591 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Signify Health Inc. [SGFY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SGFY shares is $22.22 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SGFY stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Signify Health Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on May 16, 2022. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on March 30, 2022, representing the official price target for Signify Health Inc. stock. Previously, the target price had yet another raise from $20 to $21, while UBS kept a Buy rating on SGFY stock.
The Average True Range (ATR) for Signify Health Inc. is set at 1.11, with the Price to Sales ratio for SGFY stock in the period of the last 12 months amounting to 3.40. The Price to Book ratio for the last quarter was 1.82, with the Price to Cash per share for the same quarter was set at 2.02. Price to Free Cash Flow for SGFY in the course of the last twelve months was 861.60 with Quick ratio for the last quarter at 4.80.
SGFY stock trade performance evaluation
Signify Health Inc. [SGFY] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.52. With this latest performance, SGFY shares dropped by -13.40% in over the last four-week period, additionally sinking by -9.20% over the last 6 months – not to mention a drop of -50.58% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SGFY stock in for the last two-week period is set at 41.91, with the RSI for the last a single of trading hit 40.56, and the three-weeks RSI is set at 42.70 for Signify Health Inc. [SGFY]. The present Moving Average for the last 50 days of trading for this stock 15.02, while it was recorded at 13.39 for the last single week of trading, and 16.24 for the last 200 days.
Signify Health Inc. [SGFY]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Signify Health Inc. [SGFY] shares currently have an operating margin of +8.34 and a Gross Margin at +40.41. Signify Health Inc.’s Net Margin is presently recorded at +2.55.
Return on Equity for this stock inclined to 1.95, with Return on Assets sitting at 1.08.
Signify Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 4.80.
Earnings per share (EPS) analysis for Signify Health Inc. [SGFY] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SGFY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Signify Health Inc. go to 44.20%.
Signify Health Inc. [SGFY]: Insider Ownership positions
There are presently around $2,743 million, or 86.03% of SGFY stock, in the hands of institutional investors. The top three institutional holders of SGFY stocks are: NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. with ownership of 139,614,806, which is approximately 0% of the company’s market cap and around 5.00% of the total institutional ownership; ARK INVESTMENT MANAGEMENT LLC, holding 20,992,230 shares of the stock with an approximate value of $286.12 million in SGFY stocks shares; and NIKKO ASSET MANAGEMENT AMERICAS, INC., currently with $72.79 million in SGFY stock with ownership of nearly -3.355% of the company’s market capitalization.
Positions in Signify Health Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 87 institutional holders increased their position in Signify Health Inc. [NYSE:SGFY] by around 10,694,770 shares. Additionally, 64 investors decreased positions by around 9,632,798 shares, while 19 investors held positions by with 180,915,626 shares. The mentioned changes placed institutional holdings at 201,243,194 shares, according to the latest SEC report filing. SGFY stock had 47 new institutional investments in for a total of 2,791,769 shares, while 24 institutional investors sold positions of 5,731,117 shares during the same period.